Apoptotic and cell cycle response to homoharringtonine and harringtonine in wild and mutant p53 hepatocarcinoma cells.
D P FrancoB I de BiaziT A ZanettiL A MarquesLuan Vitor Alves de LimaS R LepriMario Sergio MantovaniPublished in: Human & experimental toxicology (2020)
This study aimed to evaluate the modes of action of harringtonine (HT) and homoharringtonine (HHT) alkaloids in cell with wild (HepG2/C3A) and mutant p53 (HuH-7.5). We performed assays for cytotoxicity, genotoxicity, induction of apoptosis, cell cycle phase, and membrane integrity. Obtained data were compared with the relative expression of mRNA of genes related to proliferation, apoptosis, cell cycle control, metabolism of xenobiotics, and reticulum endoplasmic stress. The relative expression of the genes showed an increase in apoptosis-inducing mRNAs, such as TNF and BBC3, as well as a reduction in BCL2 and BAK. The mRNAs of CYP2E1 and CYP2C19 xenobiotic metabolism genes increased in both lineages, while CYP3A4 increased only in the HuH-7.5 lineage. The mRNA expression of endoplasmic reticulum (ER) stress genes (ERN1 and EIF2AK3) was shown to increase in HHT and HT treatments. A similar increase was recorded in the mRNA expression of the TRAF2 gene. The changes observed in this study support the hypothesis that ER stress was more strongly associated with TNF induction, causing cell death by apoptosis in p53 mutant cells. This result with wild and mutant p53 cells may have clinical implications in the use of these compounds.
Keyphrases
- cell cycle arrest
- cell cycle
- cell death
- cell proliferation
- induced apoptosis
- pi k akt
- endoplasmic reticulum stress
- genome wide
- oxidative stress
- signaling pathway
- genome wide analysis
- genome wide identification
- poor prognosis
- rheumatoid arthritis
- single cell
- wild type
- gene expression
- binding protein
- dna methylation
- stem cells
- genetic diversity
- electronic health record
- long non coding rna
- bone marrow
- anti inflammatory